IDF Europe Symposium at ATTD 2026 | "From diabetes detection to cure: turning vision into reality"

Date and time: 13 March 2026, 12:30 - 13 March 2026, 13:30 (CET)
Location: International Barcelona Convention Center, Plaça de Willy Brandt, Barcelona, Spain

Date and time: March 13, 2026 | 12:30-13:30

Location: Hall 113, CCIB Convention Center, Barcelona


On March 13, during the International Conference on Advanced Technologies & Treatments for Diabetes (ATTD), IDF Europe will hold a symposium titled “From diabetes detection to cure: turning vision into reality”.

The session will explore how innovation and early intervention can improve outcomes for people living with, or at risk of, diabetes, with a focus on three key areas: early-stage type 1 diabetes detection and monitoring, with considerations on the importance of language and communication; protecting heart health through effective diabetes prevention and management; and the use of continuous glucose monitoring (CGM) technologies in the prevention and management of obesity and diabetes.

Programme

Moderator: Jaivir Pall, IDF Europe Board Member

12:30-12:35 | Introduction

  • Prof. Tadej Battelino, IDF Europe Regional Chair

12:35-12:55 | Early-Stage Type 1 Diabetes: Detection, Monitoring and Communication

  • “An international consensus on the detection and monitoring of early-stage type 1 diabetes: a roadmap to European implementation”
    Dr Sufyan Hussain, Department of Diabetes, School of Cardiovascular, Metabolic Medicine and Sciences, King’s College London, and IDF Europe Board Member
  • “#LanguageMatters in population screening for stage 1 T1D”
    Marissa Town, Clinical Director at Children With Diabetes, USA

12:55-13:10 | Protecting Heart Health Through Effective Diabetes Prevention and Management

  • “Cardiovascular disease prevention for people with dysglycaemia and diabetes”
    Prof. Tsvetalina Tankova, Professor of Endocrinology, Chair in Endocrinology & Vice Rector at the Medical University of Sofia, Bulgaria, and President of the Bulgarian Society of Endocrinology

13:10-13:25 | Using CGMs for the Prevention and Management of Obesity and Diabetes

  • “The use of continuous glucose monitoring in people living with obesity, intermediate hyperglycaemia or type 2 diabetes”
    Dr. Sanja Klobučar, Associate Professor of Internal Medicine & Head of the Outpatient Clinic and Educational Center for Diabetes and Obesity, Clinical Hospital Center Rijeka, Croatia, and Vice President, Croatian Society for Diabetes and Metabolic Disorders and Croatian Society for Obesity

13:25-13:30 | Closing remarks

  • Prof. Tadej Battelino, IDF Europe Regional Chair

Lunch boxes will be provided for participants during the session.